These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38709240)

  • 61. Acanthamoeba keratitis related to orthokeratology.
    Lee JE; Hahn TW; Oum BS; Choi HY; Yu HS; Lee JS
    Int Ophthalmol; 2007 Feb; 27(1):45-9. PubMed ID: 17377749
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Associated factors, diagnosis and management of Acanthamoeba keratitis in a referral Center in Southern China.
    Zhong J; Li X; Deng Y; Chen L; Zhou S; Huang W; Lin S; Yuan J
    BMC Ophthalmol; 2017 Oct; 17(1):175. PubMed ID: 28969610
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Treatment of Acanthamoeba keratitis combined with fungal infection with polyhexamethylene biguanide.
    Tien SH; Sheu MM
    Kaohsiung J Med Sci; 1999 Nov; 15(11):665-73. PubMed ID: 10630064
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Acanthamoeba keratitis due to Acanthamoeba genotype T4 in a non-contact-lens wearer in Turkey.
    Ertabaklar H; Türk M; Dayanir V; Ertuğ S; Walochnik J
    Parasitol Res; 2007 Jan; 100(2):241-6. PubMed ID: 17013653
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prognostic factors affecting visual outcome in Acanthamoeba keratitis.
    Tu EY; Joslin CE; Sugar J; Shoff ME; Booton GC
    Ophthalmology; 2008 Nov; 115(11):1998-2003. PubMed ID: 18571729
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Acanthamoeba keratitis: a parasite on the rise.
    Thebpatiphat N; Hammersmith KM; Rocha FN; Rapuano CJ; Ayres BD; Laibson PR; Eagle RC; Cohen EJ
    Cornea; 2007 Jul; 26(6):701-6. PubMed ID: 17592320
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Acanthamoeba keratitis--resistance to medical therapy.
    Ficker L; Seal D; Warhurst D; Wright P
    Eye (Lond); 1990; 4 ( Pt 6)():835-8. PubMed ID: 2101116
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Miltefosine and polyhexamethylene biguanide: a new drug combination for the treatment of Acanthamoeba keratitis.
    Polat ZA; Walochnik J; Obwaller A; Vural A; Dursun A; Arici MK
    Clin Exp Ophthalmol; 2014 Mar; 42(2):151-8. PubMed ID: 23601234
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Acanthamoeba keratitis: report of three cases.
    Maudgal PC
    Bull Soc Belge Ophtalmol; 1989; 231():135-48. PubMed ID: 2488446
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The impact of topical corticosteroid use before diagnosis on the outcome of Acanthamoeba keratitis.
    Robaei D; Carnt N; Minassian DC; Dart JK
    Ophthalmology; 2014 Jul; 121(7):1383-8. PubMed ID: 24630688
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis.
    Sharma S; Garg P; Rao GN
    Br J Ophthalmol; 2000 Oct; 84(10):1103-8. PubMed ID: 11004092
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of Acanthamoeba keratitis.
    Lindquist TD
    Cornea; 1998 Jan; 17(1):11-6. PubMed ID: 9436874
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Amebaborne "Attilina massiliensis" Keratitis, France.
    Battaini A; La Scola B; Yin GHW; Hoffart L; Drancourt M
    Emerg Infect Dis; 2018 Feb; 24(2):387-389. PubMed ID: 29350163
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Systemic Miltefosine as an Adjunct Treatment of Progressive
    Naranjo A; Martinez JD; Miller D; Tonk R; Amescua G
    Ocul Immunol Inflamm; 2021 Nov; 29(7-8):1576-1584. PubMed ID: 32469616
    [No Abstract]   [Full Text] [Related]  

  • 75. Diagnosis of Acanthamoeba keratitis in vivo with confocal microscopy.
    Winchester K; Mathers WD; Sutphin JE; Daley TE
    Cornea; 1995 Jan; 14(1):10-7. PubMed ID: 7712728
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The role of topical corticosteroids in the management of Acanthamoeba keratitis.
    Park DH; Palay DA; Daya SM; Stulting RD; Krachmer JH; Holland EJ
    Cornea; 1997 May; 16(3):277-83. PubMed ID: 9143798
    [TBL] [Abstract][Full Text] [Related]  

  • 77. In vitro evaluations of topical agents to treat Acanthamoeba keratitis.
    Sunada A; Kimura K; Nishi I; Toyokawa M; Ueda A; Sakata T; Suzuki T; Inoue Y; Ohashi Y; Asari S; Iwatani Y
    Ophthalmology; 2014 Oct; 121(10):2059-65. PubMed ID: 24880905
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Acanthamoeba keratitis associated with contact lenses: six consecutive cases of successful management.
    Moore MB; McCulley JP
    Br J Ophthalmol; 1989 Apr; 73(4):271-5. PubMed ID: 2540794
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Acanthamoeba keratitis due to genotype T11 in a rigid gas permeable contact lens wearer in Spain.
    Lorenzo-Morales J; Morcillo-Laiz R; Martín-Navarro CM; López-Vélez R; López-Arencibia A; Arnalich-Montiel F; Maciver SK; Valladares B; Martínez-Carretero E
    Cont Lens Anterior Eye; 2011 Apr; 34(2):83-6. PubMed ID: 21130679
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Atypical presentation of Acanthamoeba keratitis.
    Tabin G; Taylor H; Snibson G; Murchison A; Gushchin A; Rogers S
    Cornea; 2001 Oct; 20(7):757-9. PubMed ID: 11588431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.